John Carter of Simpler Options reviews plays from the past week, some ideas around earnings and the expectation for JAN expiration.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.
Obamacare? Trumpcare? These stocks don't care.